Drug intelligence / Profile preview

PrecisePRP

Development stage
Unknown
Lead developer
VetStem Biopharma
Modality
Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intraarticular
01

Overview

PrecisePRP is a leucoreduced allogeneic pooled freeze-dried platelet-rich plasma (PRP) product designed for veterinary use, specifically for dogs and horses. It provides a species-specific source of concentrated platelets in plasma for intra-articular administration. Each vial contains 4 billion platelets at a concentration of 500,000 platelets per microliter and less than 1500 white blood cells per microliter. The product is shelf-stable at room temperature and does not require refrigeration or centrifugation prior to use—simply reconstitute with sterile water before injection. Donors are screened according to FDA CVM guidance #254, and each batch undergoes sterility, endotoxin, and potency testing. The mechanism of action involves delivering concentrated growth factors from platelets to sites of joint injury or degeneration to reduce inflammation, support cartilage repair, improve joint function, and stimulate local tissue healing processes[1][2][3][5][6][7][9]. Indications include osteoarthritis (OA), synovitis, synovial injuries due to trauma or surgery, elbow/hip dysplasia management in dogs/horses, post-surgical joint recovery support (e.g., after TPLO), immune-mediated polyarthritis (IMPA), as well as other musculoskeletal conditions[3][5][9].

Brand names
PrecisePRP
Other names
PrecisePRP CaninePrecisePRP Equine
02

Targets

TGFBR (TGF-beta receptor)PDGFR (PDGFR family)

Beyond the preview

Go deeper on PrecisePRP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PrecisePRP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call